During the past decade, Centro de Investigaciones Clinicas del Litoral conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 10 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Investigaciones Clinicas del Litoral" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Bayer" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Amgen" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Investigaciones Clinicas del Litoral" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Investigaciones Clinicas del Litoral" are "Diabetes Mellitus, Type 2" (4 trials), "Heart Failure" (4 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials) and "Heart Failure With Preserved Ejection Fraction" (2 trials). Many other conditions were trialed in "Centro de Investigaciones Clinicas del Litoral" in a lesser frequency.

Most popular intervention types in "Centro de Investigaciones Clinicas del Litoral" are "Drug" (23 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Empagliflozin" (2 trials), "Finerenone (BAY94-8862)" (2 trials), "Tirzepatide" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigaciones Clinicas del Litoral" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Investigaciones Clinicas del Litoral". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Centro de Investigaciones Clinicas del Litoral, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigaciones Clinicas del Litoral, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".